Skip to main content
. 2017 Oct 11;24(1):1549–1564. doi: 10.1080/10717544.2017.1386729

Figure 5.

Figure 5.

Selective inhibition effects and synergistic/antagonistic analysis of the inhibition effects of GE11-Ori-Se NPs on cancer cells. (A) Effects of oridonin on the viability of human esophageal cancer KYSE-150 cells, human esophageal cancer EC-9706 cells, human fibroblast-like synovial cells and human THP-1 cells, n = 3. (B) Effects of GE11-Ori-Se NPs on the viability of human esophageal cancer KYSE-150 cells, human esophageal cancer EC-9706 cells, human fibroblast-like synovial cells and human THP-1 cells, n = 3. (C) Effects of GE11-Ori-Se NPs, and the same dosage of oridonin or Chi-Se NPs on the viability of KYSE-150 cells, n = 4. (D) Isobologram examination of the growth inhibition effects of GE11-Ori-Se NPs, oridonin and Chi-Se NPs on KYSE-150 cells.